EKF Diagnostics (LON:EKF) Issues Earnings Results

EKF Diagnostics (LON:EKF) posted its earnings results on Tuesday. The company reported GBX 0.47 earnings per share (EPS) for the quarter, Digital Look Earnings reports. EKF Diagnostics had a return on equity of 8.50% and a net margin of 12.19%.

EKF Diagnostics Price Performance

EKF stock opened at GBX 24.05 on Wednesday. The business has a 50 day moving average price of GBX 25.71 and a 200 day moving average price of GBX 26.39. The company has a quick ratio of 1.77, a current ratio of 4.62 and a debt-to-equity ratio of 1.56. The stock has a market cap of £103.84 million, a price-to-earnings ratio of 17.81 and a beta of 0.53. EKF Diagnostics has a fifty-two week low of GBX 19 and a fifty-two week high of GBX 32.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.